Dr. Michael Swartwood, D.O.
What this data tells you about Dr. Swartwood
Dr. Michael Swartwood is a family medicine in Athens, TX, with 16 years in practice. Based on federal Medicare data, Dr. Swartwood performed 2,139 Medicare services across 1,475 unique beneficiaries.
Between the years covered by Open Payments, Dr. Swartwood received a total of $4,751 from 40 pharmaceutical and/or device companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Swartwood is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 258 | $78 | $240 |
| Blood draw (venipuncture) | 227 | $8 | $10 |
| Office visit, established patient (20-29 min) | 206 | $56 | $150 |
| Complete blood count (CBC) with differential | 193 | $8 | $25 |
| Comprehensive metabolic blood panel | 183 | $10 | $70 |
| Lipid panel (cholesterol and triglycerides) | 141 | $13 | $75 |
| Annual wellness visit, follow-up | 114 | $125 | $155 |
| Hemoglobin A1c test (diabetes monitoring) | 59 | $10 | $35 |
| Office visit, established patient, complex (40-54 min) | 59 | $126 | $285 |
| Ceftriaxone antibiotic injection | 56 | $0 | $20 |
| Flu vaccine administration | 55 | $29 | $30 |
| Drug injection, under skin or into muscle | 51 | $9 | $52 |
| Flu vaccine, high-dose | 50 | $69 | $70 |
| Urinalysis with microscopic exam | 46 | $3 | $22 |
| Thyroid stimulating hormone (TSH) test | 44 | $16 | $52 |
| Hospital follow-up visit, moderate complexity | 44 | $59 | $150 |
| Free thyroxine (T4) test | 34 | $9 | $110 |
| Prostate cancer screening; prostate specific antigen test (psa) | 31 | $19 | $55 |
| Chest X-ray, 2 views | 28 | $20 | $80 |
| Basic metabolic blood panel | 26 | $8 | $50 |
| Betamethasone steroid injection | 26 | $4 | $25 |
| Screening mammography | 24 | $89 | $300 |
| Bone density scan (DEXA) | 24 | $37 | $330 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 24 | $55 | $160 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 22 | $16 | $35 |
| Annual depression screening | 22 | $18 | $25 |
| Advance care planning consultation, first 30 min | 18 | $55 | $110 |
| Uric acid level test | 16 | $4 | $14 |
| Electrocardiogram (EKG), 12-lead | 16 | $9 | $55 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $38 | $85 |
| Hospital discharge day management, 30 minutes or less | 14 | $63 | $150 |
| Natriuretic peptide (heart and blood vessel protein) level | 13 | $38 | $160 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Swartwood is a clinical cardiology specialist, with above-average Medicare volume (top 12% in TX), and high industry engagement (low-engagement, top 13%), with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Swartwood experienced with office visit, established patient (30-39 min)?
Does Dr. Swartwood receive payments from pharmaceutical companies?
How do Dr. Swartwood's costs compare to other family medicines in Athens?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology